跳至主要内容
临床试验/NCT03328260
NCT03328260已完成不适用

Prospective, Muti-institute, Single Arm, Confirmative Trial Evaluating Efficacy and Safety of High Intensity Focused Ultrasound Device (RODIN) in Women With Symptomatic Uterine Leiomyoma

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2017年12月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
1
主要终点
Non perfused volume

研究概览

简要总结

Aim to evaluate the efficacy of safety of newly developed, high intensity focused ultrasound device in women with symptomatic uterine leiomyoma

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Premenopausal (FSH < 40 IU/L)
  • •Symptomatic uterine fibroids
  • •Willing to contracept during study period

排除标准

  • •Pregnant or willing to be pregnant in future
  • •Cancer in female reproductive organ is suspected or diagnosed
  • •Inflammation in female reproductive organ
  • •Poorly controlled systemic disease
  • •Hematocrit < 25%
  • •Glomerular filtration rate(GFR) <= 30ml/min
  • •Cannot tolerate contrast-enhanced MR or Contrast-enhanced ultrasound(CEUS)
  • •Cannot lie down
  • •Previous treatment for leiomyoma, any of ① myolysis, ② myomectomy within 1 year, ③ hormonal therapy longer than 7 days within 4 weeks
  • •Cannot count the number or measure volume of leiomyoma using MRI
  • •Leiomyomas are inadequate (location, volume, number) for intervention
  • •Diameter of leiomyoma is over 5 cm
  • •Leiomyoma is not enhanced
  • •Lactating women
  • •Cannot communicate properly
  • •Participating or have participated in other trials within 30 days

研究组 & 干预措施

Treatment

Experimental

干预措施: HIFU (Device)

结局指标

主要结局

Non perfused volume

时间窗: treatment day

Non perfused volume in myoma immediately after ablation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验